> Pfizer has notified health care professionals that the prescribing
>information for Trovan I.V. (alatrofloxacin mesylate injection) has been
>ameded to include information on the potential incompatibility of
>alatrofloxacin mesylate injection with two commonly used diluents, 0.9%
>sodium chloride injection, USP (usually referred to as normal saline
>solution) and Lactated Ringer's, USP.
>
>
>
>
>
------------------------------------------------------------------------
This is an automatically-generated notice. If you'd like to be removed
from the mailing list, please visit the Medicine-On-Line Discussion Forum
at <http://www.meds.com/con_faq.html>, or send an email message to:
majordomo@lists.meds.com
with the subject line blank and the body of the message containing the line:
unsubscribe mol-cancer your-email-address
where the phrase your-email-address is replaced with your actual email
address.
------------------------------------------------------------------------
